These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6417154)

  • 41. Relation of plasma oxytocin and prolactin concentrations to milk production in mothers of preterm infants: influence of stress.
    Chatterton RT; Hill PD; Aldag JC; Hodges KR; Belknap SM; Zinaman MJ
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3661-8. PubMed ID: 11061519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of oxytocin on prolactin secretion during proestrus and in different physiological or pharmacological paradigms.
    Johnston CA; Negro-Vilar A
    Endocrinology; 1988 Jan; 122(1):341-50. PubMed ID: 3335212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist.
    Tamminga CA; Neophytides A; Chase TN; Frohman LA
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1348-51. PubMed ID: 162520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Release of oxytocin and prolactin by suckling in rabbits throughout lactation.
    Fuchs AR; Cubile L; Dawood MY; Jørgensen FS
    Endocrinology; 1984 Feb; 114(2):462-9. PubMed ID: 6690286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
    Kremer JA; Borm G; Schellekens LA; Thomas CM; Rolland R
    J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers.
    Andreotti AC; Pianezzola E; Persiani S; Pacciarini MA; Strolin Benedetti M; Pontiroli AE
    J Clin Endocrinol Metab; 1995 Mar; 80(3):841-5. PubMed ID: 7883840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship between suckling-induced prolactin response and lactogenesis.
    Howie PW; McNeilly AS; McArdle T; Smart L; Houston M
    J Clin Endocrinol Metab; 1980 Apr; 50(4):670-3. PubMed ID: 7364925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alcoholism abolishes the gamma-aminobutyric acid (GABA)ergic control of GH secretion in humans.
    Vescovi PP; Volpi R; Coiro V
    Alcohol; 1998 Nov; 16(4):325-8. PubMed ID: 9818985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolactin response to dopamine and valproate administration in breast cancer patients.
    Stalldecker GB; Pigni J; Fuentes AM; Vegh I
    Biomed Pharmacother; 1989; 43(4):301-6. PubMed ID: 2506942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The GABAergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate.
    Coiro V; Davoli C; Volpi R; Sorini E; Voltini E; Rossi G; Delsignore R; Gnudi A; Chiodera P
    Acta Diabetol Lat; 1986; 23(1):51-5. PubMed ID: 3012924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Domperidone in defective and insufficient lactation.
    Petraglia F; De Leo V; Sardelli S; Pieroni ML; D'Antona N; Genazzani AR
    Eur J Obstet Gynecol Reprod Biol; 1985 May; 19(5):281-7. PubMed ID: 3894101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Augmentation of puerperal lactation by oral administration of sulpiride.
    Aono T; Shioji T; Aki T; Hirota K; Nomura A; Kurachi K
    J Clin Endocrinol Metab; 1979 Mar; 48(3):478-82. PubMed ID: 429499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of sodium valproate on plasma somatostatin and insulin in humans.
    Kusunoki M; Yamamura T; Ichii S; Fujita S; Nakai T; Utsunomiya J
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1060-3. PubMed ID: 2903170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secretion of prolactin after acute and chronic stimulation of the breast: effect of timing during the menstrual cycle.
    Ratner RE; Sherry SH; Guay AT
    Fertil Steril; 1982 Oct; 38(4):410-4. PubMed ID: 7117568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Piribedil inhibition of prolactin release induced by mechanical breast emptying in puerperal women.
    Alagna S; Lodico G; Devilla L; Masala A; Delitala G; Rovasio PP; Stoppelli I
    Clin Endocrinol (Oxf); 1979 Sep; 11(3):301-5. PubMed ID: 389484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on metoclopramide (MCP) loading test during pregnancy and puerperium for the evaluation of lactating capacity].
    Aisaka K; Tomonari R; Kaneda S; Yoshimatsu J; Tawada T; Kokuho K; Tsuzuki H; Nojima M; Sasaki S; Toriya Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):503-8. PubMed ID: 2056225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improvement of defective lactation by using oral metoclopramide.
    Guzmán V; Toscano G; Canales ES; Zárate A
    Acta Obstet Gynecol Scand; 1979; 58(1):53-5. PubMed ID: 369279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decrease in human plasma prolactin levels by oral prostaglandin E2 in early puerperium.
    Caminiti F; De Murtas M; Parodo G; Lecca U; Nasi A
    J Endocrinol; 1980 Dec; 87(3):333-7. PubMed ID: 7452120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood oxygen partial pressure affects plasma prolactin concentration in humans.
    Strüder HK; Hollmann W; Weicker H; Schiffer T; Weber K
    Acta Physiol Scand; 1999 Mar; 165(3):265-9. PubMed ID: 10192175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The modification of the ethanol withdrawal syndrome in rats by di-n-propylacetate.
    Noble EP; Gillies R; Vigran R; Mandel P
    Psychopharmacologia; 1976 Mar; 46(2):127-31. PubMed ID: 781711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.